Meredith M Course

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Cerebral Ischemia

Ejection Fraction

Cognitive Decline

Top Venues

Genome research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel N Smukowski, Cassidy Danyko, Jenna Somberg, Eli J Kaufman, Meredith M Course, Nadia Postupna, Melissa Barker-Haliski, C Dirk Keene, Paul N Valdmanis
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease. PLoS genetics 20 (7) (2024)
Samuel N Smukowski, Cassidy Danyko, Jenna Somberg, Eli J Kaufman, Meredith M Course, Nadia Postupna, Melissa Barker-Haliski, C Dirk Keene, Paul N Valdmanis
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease. PLoS genetics 20 (7) (2024)
Samuel N Smukowski, Cassidy Danyko, Jenna Somberg, Eli J Kaufman, Meredith M Course, Nadia Postupna, Melissa Barker-Haliski, C Dirk Keene, Paul N Valdmanis
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease. PLoS genetics 20 (7) (2024)
Samuel N Smukowski, Cassidy Danyko, Jenna Somberg, Eli J Kaufman, Meredith M Course, Nadia Postupna, Melissa Barker-Haliski, C Dirk Keene, Paul N Valdmanis
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease. PLoS genetics 20 (7) (2024)
Samuel N Smukowski, Cassidy Danyko, Jenna Somberg, Eli J Kaufman, Meredith M Course, Nadia Postupna, Melissa Barker-Haliski, C Dirk Keene, Paul N Valdmanis
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's disease. PLoS genetics 20 (7) (2024)
Meredith M Course, Arvis Sulovari, Kathryn Gudsnuk, Evan E Eichler, Paul N Valdmanis
Characterizing nucleotide variation and expansion dynamics in human-specific variable number tandem repeats. Genome research 31 (8) (2021)
Chang Li, Meredith M Course, Iain A McNeish, Charles W Drescher, Paul N Valdmanis, André Lieber
Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models. Cancer research 80 (3) (2019)